OSE Immunotherapeutics S.A.
Healthcare · EUR · EPA
Price
€4.73
Cap
€53.82M
Earnings
—
30d Trend
+18.5%
76% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 50×Macro 0.99 (−1%)=50
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate OSE Immunotherapeutics S.A. at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 73/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+20.3%
3 MONTHS
+10.4%
12 MONTHS
-19.7%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (73) and Fundamentals (70) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 76%. I classify this as a speculative position — elevated volatility at 76% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.